b'PFE\nBought since January 25\nGlaxoSmithKline Plc is a global healthcare company which engages in developing\xef\xbe\x8b manufacturing\xef\xbe\x8b and marketing of pharmaceutical products including vaccines\xef\xbe\x8b over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals\xef\xbe\x8b Pharmaceuticals R&D\xef\xbe\x8b Vaccines and Consumer Healthcare. The Pharmaceuticals business researches\xef\xbe\x8b develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including\xef\xbe\x8b hepatitis A and B\xef\xbe\x8b diphtheria\xef\xbe\x8b tetanus and whooping cough\xef\xbe\x8b measles\xef\xbe\x8b mumps and rubella\xef\xbe\x8b polio\xef\xbe\x8b typhoid\xef\xbe\x8b influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6\xef\xbe\x8b 1999 and is headquartered in Brentford\xef\xbe\x8b \xe2\x80\xa6 read more\n'